» Articles » PMID: 29622652

Hepatic Thrombopoietin is Required for Bone Marrow Hematopoietic Stem Cell Maintenance

Overview
Journal Science
Specialty Science
Date 2018 Apr 7
PMID 29622652
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cell (HSC) maintenance depends on extrinsic cues. Currently, only local signals arising from the bone marrow niche have been shown to maintain HSCs. However, it is not known whether systemic factors also sustain HSCs. We assessed the physiological source of thrombopoietin (TPO), a key cytokine required for maintaining HSCs. Using knock-in mice, we showed that TPO is expressed by hepatocytes but not by bone marrow cells. Deletion of from hematopoietic cells, osteoblasts, or bone marrow mesenchymal stromal cells does not affect HSC number or function. However, when is deleted from hepatocytes, bone marrow HSCs are depleted. Thus, a cross-organ factor, circulating TPO made in the liver by hepatocytes, is required for bone marrow HSC maintenance. Our results demonstrate that systemic factors, in addition to the local niche, are a critical extrinsic component for HSC maintenance.

Citing Articles

Haematometabolism rewiring in atherosclerotic cardiovascular disease.

Yvan-Charvet L, Barouillet T, Borowczyk C Nat Rev Cardiol. 2025; .

PMID: 39743562 DOI: 10.1038/s41569-024-01108-9.


Deciphering hematopoietic stem cell development: key signaling pathways and mechanisms.

Morino-Koga S, Yokomizo T Front Cell Dev Biol. 2024; 12:1510198.

PMID: 39717844 PMC: 11663937. DOI: 10.3389/fcell.2024.1510198.


Effect of bone marrow niche on hematopoietic stem cells.

Niazi V, Ghafouri-Fard S Histochem Cell Biol. 2024; 163(1):19.

PMID: 39714560 DOI: 10.1007/s00418-024-02348-z.


Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip.

Georgescu A, Oved J, Galarraga J, Cantrell T, Mehta S, Dulmovits B Cell Stem Cell. 2024; 31(12):1847-1864.e6.

PMID: 39642865 PMC: 11651161. DOI: 10.1016/j.stem.2024.11.003.


Versatility of megakaryocytes in homeostasis and disease.

Wang D, Xie J, Zhao M Blood Sci. 2024; 6(4):e00212.

PMID: 39620204 PMC: 11608743. DOI: 10.1097/BS9.0000000000000212.


References
1.
Mikkola H, Orkin S . The journey of developing hematopoietic stem cells. Development. 2006; 133(19):3733-44. DOI: 10.1242/dev.02568. View

2.
Ghilardi N, Wiestner A, Skoda R . Thrombopoietin production is inhibited by a translational mechanism. Blood. 1998; 92(11):4023-30. View

3.
Alexander W, Roberts A, Nicola N, Li R, Metcalf D . Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996; 87(6):2162-70. View

4.
Nakamura-Ishizu A, Takubo K, Fujioka M, Suda T . Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem Biophys Res Commun. 2014; 454(2):353-7. DOI: 10.1016/j.bbrc.2014.10.095. View

5.
Kimura S, Roberts A, Metcalf D, Alexander W . Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A. 1998; 95(3):1195-200. PMC: 18717. DOI: 10.1073/pnas.95.3.1195. View